share_log

UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5

Benzinga ·  Nov 30, 2023 08:43

UBS analyst A.J. Rice initiates coverage on Pediatrix Medical Group (NYSE:MD) with a Neutral rating and announces Price Target of $9.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment